Table of Contents

1. Research Objectives and Assumptions

   • Research Objectives

   • Assumptions

   • Abbreviations

2. Market Preview

   • Report Description

     • Market Definition and Scope

   • Executive Summary

     • Market Snapshot, By Drug Class

     • Market Snapshot, By Application

     • Market Snapshot, By Distribution Channel

     • Market Snapshot, By Region

   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics

     • Drivers

     • Restraints

     • Market Opportunities

   • Impact Analysis

   • Recent Product Launches

   • Epidemiology

   • Merger, Acquisition, and Collaboration

   • Regulatory Scenario

   • Key Developments

   • PEST Analysis

   • Partnership Scenario

   • Brand and Pricing Analysis

   • Distributors Landscape

   • Porters Analysis

   • Technological Advancements

   • Key Developments

   • Market Trend

   • Future Prospective

   • Top Market Players by Revenue

4. Hyperphosphatemia Drugs Market By Drug Class, 2025–2032, (US$ Billion)

   • Introduction

     • Market Share Analysis, 2025 and 2032 (%)

     • Y-o-Y Growth Analysis, 2021–2032

     • Segment Trends

   • Calcium-Based Phosphate Binders

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

   • Non-Calcium-Based Phosphate Binders

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

   • Iron-Based Phosphate Binders

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

   • Others

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

5. Hyperphosphatemia Drugs Market By Application, 2025-2032, (US$ Billion)

   • Introduction

     • Market Share Analysis, 2025 and 2032 (%)

     • Y-o-Y Growth Analysis, 2021–2032

     • Segment Trends

   • Dialysis Patients

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

   • Non-Dialysis Chronic Kidney Disease (CKD) Patients

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

   • Pediatric Patients

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

   • Others

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

6. Hyperphosphatemia Drugs Market By Distribution Channel, 2025-2032, (US$ Billion)

   • Introduction

     • Market Share Analysis, 2025 and 2032 (%)

     • Y-o-Y Growth Analysis, 2021–2032

     • Segment Trends

   • Hospital Pharmacies

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

   • Retail Pharmacies

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

   • Online Pharmacies

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

   • Others

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

7. Hyperphosphatemia Drugs Market By Region, 2025-2032, (US$ Billion)

   • Introduction

     • Market Share Analysis, By Region, 2025 and 2032 (%)

     • Y-o-Y Growth Analysis, For Regions, 2021–2032

     • Regional Trends

   • North America

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2025-2032, (US$ Billion)

     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2025-2032, (US$ Billion)

     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2025-2032, (US$ Billion)

     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

       • U.S.

       • Canada

   • Latin America

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2025-2032, (US$ Billion)

     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2025-2032, (US$ Billion)

     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2025-2032, (US$ Billion)

     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

       • Brazil

       • Mexico

       • Argentina

       • Rest of Latin America

   • Europe

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2025-2032, (US$ Billion)

     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2025-2032, (US$ Billion)

     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2025-2032, (US$ Billion)

     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

       • U.K.

       • Germany

       • Italy

       • France

       • Spain

       • Russia

       • Benelux

       • Denmark

       • Norway

       • Sweden

       • Rest of Europe

   • Asia Pacific

     • Introduction

     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2025-2032, (US$ Billion)

     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2025-2032, (US$ Billion)

     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2025-2032, (US$ Billion)

     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

       • China

       • Taiwan

       • India

       • Japan

       • Indonesia

       • Malaysia

       • Philippines

       • Singapore

       • Australia

       • South Korea

       • Rest of Asia Pacific

o Middle East & Africa

• Introduction

• Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2025-2032, (US$ Billion)

• Market Size and Forecast, and Y-o-Y Growth, By Application, 2025-2032, (US$ Billion)

• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2025-2032, (US$ Billion)

• Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

  • Bahrain

  • Kuwait

  • Oman

  • Qatar

  • Saudi Arabia

  • UAE

  • Israel

  • South Africa

  • North Africa

  • Central Africa

  • Rest of the Middle East

7. Competitive Landscape

   • Amgen Inc.

     • Company Highlights

     • Product Portfolio

     • Key Highlights

     • Financial Performance

     • Market Strategies

   • Shire Pharmaceuticals

     • Company Highlights

     • Product Portfolio

     • Key Highlights

     • Financial Performance

     • Market Strategies

   • Vifor Pharma

     • Company Highlights

     • Product Portfolio

     • Key Highlights

     • Financial Performance

     • Market Strategies

   • Akebia Therapeutics

     • Company Highlights

     • Product Portfolio

     • Key Highlights

     • Financial Performance

     • Market Strategies

   • Kyowa Kirin Co. Ltd.

     • Company Highlights

     • Product Portfolio

     • Key Highlights

     • Financial Performance

     • Market Strategies

   • Nipro Corporation

     • Company Highlights

     • Product Portfolio

     • Key Highlights

     • Financial Performance

     • Market Strategies

   • Baxter International Inc.

     • Company Highlights

     • Product Portfolio

     • Key Highlights

     • Financial Performance

     • Market Strategies

   • Taiho Pharmaceutical Co. Ltd.

     • Company Highlights

     • Product Portfolio

     • Key Highlights

     • Financial Performance

     • Market Strategies

   • Takeda Pharmaceutical Company Limited

     • Company Highlights

     • Product Portfolio

     • Key Highlights

     • Financial Performance

     • Market Strategies

   • Otsuka Holdings Co., Ltd.

     • Company Highlights

     • Product Portfolio

     • Key Highlights

     • Financial Performance

     • Market Strategies

8. Section

   • Research Methodology

   • About Us